{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:58Z","timestamp":1792784878219,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18SFRN33900097, 18SFRN33900136, 18SFRN33970010"],"award-info":[{"award-number":["18SFRN33900097, 18SFRN33900136, 18SFRN33970010"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ChromaDex provided the nicotinamide riboside. ReserveAge provided the resveratrol."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>People with lower extremity peripheral artery disease (PAD) have increased oxidative stress, impaired mitochondrial activity, and poor walking performance. NAD+ reduces oxidative stress\u00a0and is an essential cofactor for mitochondrial respiration. Oral nicotinamide riboside (NR) increases bioavailability of NAD+ in humans. Among 90 people with PAD, this randomized double-blind clinical trial assessed whether 6-months of NR, with and without resveratrol, improves 6-min walk distance, compared to placebo, at 6-month follow-up. At 6-month follow-up, compared to placebo, NR significantly improved 6-min walk (+7.0 vs. \u221210.6 meters, between group difference: +17.6 (90% CI:\u2009+\u20091.8,+\u221e). Among participants who took at least 75% of study pills, compared to placebo, NR improved 6-min walk by 31.0 meters and NR + resveratrol improved 6-min walk by 26.9 meters. In this work, NR meaningfully improved 6-min walk, and resveratrol did not add benefit to NR alone in PAD. A larger clinical trial to confirm these findings is needed. Clinical Trials.gov registration: NCT03743636.<\/jats:p>","DOI":"10.1038\/s41467-024-49092-5","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T05:02:22Z","timestamp":1718254942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-7619","authenticated-orcid":false,"given":"Mary M.","family":"McDermott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-2948","authenticated-orcid":false,"given":"Christopher R.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Domanchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-0879","authenticated-orcid":false,"given":"Clara B.","family":"Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Criqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6273-1613","authenticated-orcid":false,"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-2439","authenticated-orcid":false,"given":"Philip","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack M.","family":"Guralnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina R.","family":"Kibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Kosmac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lloyd-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9340-0705","authenticated-orcid":false,"given":"Charlotte A.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sufit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Wohlgemuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"Leeuwenburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"49092_CR1","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1001\/jama.2021.2126","volume":"325","author":"TS Polonsky","year":"2021","unstructured":"Polonsky, T. S. & McDermott, M. M. Lower extremity peripheral artery disease without chronic limb-threatening ischemia: a review. JAMA 325, 2188\u20132198 (2021).","journal-title":"JAMA"},{"key":"49092_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1479-5876-11-230","volume":"11","author":"DJ Weiss","year":"2013","unstructured":"Weiss, D. J. et al. Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease. J. Transl. Med. 11, 230\u2013239 (2013).","journal-title":"J. Transl. Med."},{"key":"49092_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.injury.2011.03.008","volume":"12","author":"S Gillani","year":"2012","unstructured":"Gillani, S., Cao, J., Suzuki, T. & Hak, D. J. The effect of ischemia reperfusion injury on skeletal muscle. Injury 12, 670\u2013675 (2012).","journal-title":"Injury"},{"key":"49092_CR4","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1161\/ATVBAHA.120.313831","volume":"40","author":"MM McDermott","year":"2020","unstructured":"McDermott, M. M. et al. Skeletal muscle pathology in peripheral artery disease: a brief review. Arterioscler. Thromb. Vasc. Biol. 40, 2577\u20132585 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"49092_CR5","doi-asserted-by":"publisher","first-page":"e015929","DOI":"10.1161\/JAHA.118.015929","volume":"9","author":"K Kosmac","year":"2020","unstructured":"Kosmac, K. et al. Correlations of calf muscle macrophage content with muscle properties and walking performance in peripheral artery disease. J. Am. Heart Assoc. 9, e015929 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"49092_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-1030-6","volume":"14","author":"SH White","year":"2016","unstructured":"White, S. H. et al. Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study. J. Transl. Med. 14, 284 (2016).","journal-title":"J. Transl. Med."},{"key":"49092_CR7","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/CIRCRESAHA.122.322325","volume":"132","author":"L Ferrucci","year":"2023","unstructured":"Ferrucci, L. et al. Transcriptomic and proteomic of gastrocnemius muscle in peripheral artery disease. Cir. Res. 132, 1428\u20131443 (2023).","journal-title":"Cir. Res."},{"key":"49092_CR8","doi-asserted-by":"publisher","first-page":"e13943","DOI":"10.15252\/emmm.202113943","volume":"13","author":"R Zapata-Perez","year":"2021","unstructured":"Zapata-Perez, R., Wanders, R. J. A. & van Karnebeek, C. D. M. NAD+ homeostasis in human health and disease. EMBO Mol. Med. 13, e13943 (2021).","journal-title":"EMBO Mol. Med."},{"key":"49092_CR9","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/gerona\/glad106","volume":"78","author":"K Freeberg","year":"2023","unstructured":"Freeberg, K. et al. Dietary supplementation with NAD+-boosting compounds in humans: current knowledge and future directions. J. Gerontol: Med. Sci. 78, 2435\u20132448 (2023).","journal-title":"J. Gerontol: Med. Sci."},{"key":"49092_CR10","doi-asserted-by":"publisher","first-page":"10268","DOI":"10.1073\/pnas.1003833107","volume":"107","author":"Z Chen","year":"2010","unstructured":"Chen, Z. et al. Shear stress, SIRT1, and vascular homeostasis. Proc. Natl Acad. Sci. USA 107, 10268\u201310273 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"49092_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","volume":"28","author":"YS Elhassan","year":"2019","unstructured":"Elhassan, Y. S. et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 28, 1717\u20131728 (2019).","journal-title":"Cell Rep."},{"key":"49092_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/acel.12461","volume":"15","author":"NE de Picciotto","year":"2016","unstructured":"de Picciotto, N. E. et al. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell 15, 522\u2013530 (2016).","journal-title":"Aging Cell"},{"key":"49092_CR13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaf2693","volume":"352","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352, 1436\u20131443 (2016).","journal-title":"Science"},{"key":"49092_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/emmm.201403943","volume":"6","author":"NA Khan","year":"2014","unstructured":"Khan, N. A. et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol. Med. 6, 721\u2013731 (2014).","journal-title":"EMBO Mol. Med."},{"key":"49092_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens, C. R. et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat. Commun. 9, 1286 (2018).","journal-title":"Nat. Commun."},{"key":"49092_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12948","volume":"7","author":"SAJ Trammell","year":"2016","unstructured":"Trammell, S. A. J. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).","journal-title":"Nat. Commun."},{"key":"49092_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature01960","volume":"425","author":"K Howitz","year":"2003","unstructured":"Howitz, K. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191\u2013196 (2003).","journal-title":"Nature"},{"key":"49092_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jvs.2020.03.052","volume":"73","author":"MM McDermott","year":"2021","unstructured":"McDermott, M. M. et al. Meaningful change in 6-min walk in people with peripheral artery disease. J. Vasc. Surg. 73, 267\u2013276 (2021).","journal-title":"J. Vasc. Surg."},{"key":"49092_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1358863X18762599","volume":"23","author":"AW Gardner","year":"2018","unstructured":"Gardner, A. W., Montgomery, P. S. & Wang, M. Minimal clinically important differences in treadmill, 6-min walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease. Vasc. Med. 23, 349\u2013357 (2018).","journal-title":"Vasc. Med."},{"key":"49092_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ajcn\/nqy132","volume":"108","author":"OL Dollerup","year":"2018","unstructured":"Dollerup, O. L. et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. Am. J. Clin. Nutr. 108, 343\u2013353 (2018).","journal-title":"Am. J. Clin. Nutr."},{"key":"49092_CR21","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1210\/jc.2019-01081","volume":"104","author":"OL Dollerup","year":"2019","unstructured":"Dollerup, O. L. et al. Effects of nicotinamide riboside on endocrine pancreatic function and incretin hormones in nondiabetic men with obesity. J. Clin. Endocrinol. Metab. 104, 5703\u20135714 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"49092_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1113\/JP278752","volume":"598","author":"OL Dollerup","year":"2020","unstructured":"Dollerup, O. L. et al. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men. J. Physiol. 598, 731\u2013754 (2020).","journal-title":"J. Physiol."},{"key":"49092_CR23","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1038\/s41598-019-46120-z","volume":"9","author":"D Conze","year":"2019","unstructured":"Conze, D., Brennar, C. & Kruger, C. Safety and metabolism of long-term administration of NIAGEN in a randomized, double-blinded, placebo-controlled clinical trial of healthy overweight adults. Sci. Rep. 9, 9772 (2019).","journal-title":"Sci. Rep."},{"key":"49092_CR24","first-page":"1183","volume":"7","author":"DD Wang","year":"2022","unstructured":"Wang, D. D. et al. Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fracture. JACC Clin. Transl. Sci. 7, 1183\u20131196 (2022).","journal-title":"JACC Clin. Transl. Sci."},{"key":"49092_CR25","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1067\/mva.2000.108640","volume":"32","author":"MM McDermott","year":"2000","unstructured":"McDermott, M. M. et al. Lower ankle\/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J. Vasc. Surg. 32, 1164\u20131171 (2000).","journal-title":"J. Vasc. Surg."},{"key":"49092_CR26","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","volume":"126","author":"V Aboyans","year":"2012","unstructured":"Aboyans, V. et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 126, 2890\u20132909 (2012).","journal-title":"Circulation"},{"key":"49092_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.0.CO;2-9","volume":"13","author":"R Heun","year":"1998","unstructured":"Heun, R., Papassotiropoulos, A. & Jennssen, F. The validity of psychometric instruments for detection of dementia in the elderly general population. Int. J. Geriatr. Psychiatry 13, 368\u2013380 (1998).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"49092_CR28","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2021.2536","volume":"325","author":"MM McDermott","year":"2021","unstructured":"McDermott, M. M. et al. Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial. JAMA 325, 1266\u20131276 (2021).","journal-title":"JAMA"},{"key":"49092_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/1358863X9600100112","volume":"1","author":"MH Criqui","year":"1996","unstructured":"Criqui, M. H. et al. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc. Med. 1, 65\u201371 (1996).","journal-title":"Vasc. Med."},{"key":"49092_CR30","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/CIRCRESAHA.114.303517","volume":"116","author":"MM McDermott","year":"2015","unstructured":"McDermott, M. M. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ. Res. 116, 1540\u20131550 (2015).","journal-title":"Circ. Res."},{"key":"49092_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.114.007002","volume":"130","author":"MM McDermott","year":"2014","unstructured":"McDermott, M. M. et al. 6-min walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation 130, 61\u201368 (2014).","journal-title":"Circulation"},{"key":"49092_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1249\/00005768-199104000-00003","volume":"23","author":"AW Gardner","year":"1991","unstructured":"Gardner, A. W. et al. Progressive vs. single-stage treadmill tests for evaluation of claudication. Med. Sci. Sports Exerc. 23, 402\u2013408 (1991).","journal-title":"Med. Sci. Sports Exerc."},{"key":"49092_CR33","first-page":"142","volume":"2","author":"JG Regensteiner","year":"1990","unstructured":"Regensteiner, J. G. et al. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J. Vasc. Med. Biol. 2, 142\u2013152 (1990).","journal-title":"J. Vasc. Med. Biol."},{"key":"49092_CR34","unstructured":"Ware, J. E., Snow, K. K., Kosinski, M. A. & Gandek, B. G. SF-36 Health Survey: Manual And Interpretation Guide (The Health Institute, New England Medical Center, 1993)."},{"key":"49092_CR35","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/acr.22392","volume":"66","author":"MM Ward","year":"2014","unstructured":"Ward, M. M., Guthrie, L. C. & Alba, M. I. Clinically important changes in Short Form 36 Health Survey Scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness. Arthritis Care Res. 66, 1783\u20131789 (2014).","journal-title":"Arthritis Care Res."},{"key":"49092_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6649-13-5","volume":"13","author":"LA Kelly","year":"2013","unstructured":"Kelly, L. A. et al. Validity of actigraphs uniaxial and triaxial accelerometers for assessment of physical activity in adults in laboratory conditions. BMC Med. Phys. 13, 5 (2013).","journal-title":"BMC Med. Phys."},{"key":"49092_CR37","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1126\/science.1243417","volume":"342","author":"CB Peek","year":"2013","unstructured":"Peek, C. B. et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 342, 6158 (2013).","journal-title":"Science"},{"key":"49092_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2013.7231","volume":"310","author":"MM McDermott","year":"2013","unstructured":"McDermott, M. M. et al. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA 310, 57\u201365 (2013).","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1038\/s41467-024-51289-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49092-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T02:03:22Z","timestamp":1723514602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49092-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["49092"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-49092-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"23 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-024-51289-7","URL":"https:\/\/doi.org\/10.1038\/s41467-024-51289-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. McDermott reports research funding from Helixmith and other research support from ArtAssist, and Mars. The remaining authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5046"}}